8-K/A filed September 22, 2023, 7:59 PM ET ticker PACB CIK 0001299130

M&A confidence high sentiment neutral materiality 0.60

Pacific Biosciences to issue ~8.9M shares and $101M cash for Omniome milestone

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

On Sep 20, 2023, PacBio achieved a commercial milestone under the Omniome merger agreement.
Former Omniome holders will receive approx. $101M cash + 8.9M shares (valued at ~$100M based on 20-day VWAP).
Shares issuance expected on or about October 4, 2023.

item 3.02

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. filing history →

Source: SEC EDGAR

accession 0001104659-23-103181

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.